These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27259247)

  • 21. Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease.
    Menet R; Bourassa P; Calon F; ElAli A
    Neurochem Int; 2020 Dec; 141():104881. PubMed ID: 33068684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease of ERK/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer's disease.
    Feld M; Krawczyk MC; Sol Fustiñana M; Blake MG; Baratti CM; Romano A; Boccia MM
    J Alzheimers Dis; 2014; 40(1):69-82. PubMed ID: 24334722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of hippocampal tau protein phosphorylation in isoflurane-induced cognitive dysfunction in transgenic APP695 mice.
    Li C; Liu S; Xing Y; Tao F
    Anesth Analg; 2014 Aug; 119(2):413-419. PubMed ID: 24977637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice.
    Cuadrado-Tejedor M; Ricobaraza A; Frechilla D; Franco R; Pérez-Mediavilla A; Garcia-Osta A
    J Alzheimers Dis; 2012; 28(3):567-78. PubMed ID: 22045482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
    Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
    J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
    Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits.
    Sotiropoulos I; Catania C; Pinto LG; Silva R; Pollerberg GE; Takashima A; Sousa N; Almeida OF
    J Neurosci; 2011 May; 31(21):7840-7. PubMed ID: 21613497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
    Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR
    Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease.
    Hamm V; Héraud C; Bott JB; Herbeaux K; Strittmatter C; Mathis C; Goutagny R
    Sci Adv; 2017 Feb; 3(2):e1601068. PubMed ID: 28275722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice.
    Mendell AL; Creighton SD; Wilson HA; Jardine KH; Isaacs L; Winters BD; MacLusky NJ
    Neuroscience; 2020 Mar; 429():185-202. PubMed ID: 31954826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease.
    Baranger K; Marchalant Y; Bonnet AE; Crouzin N; Carrete A; Paumier JM; Py NA; Bernard A; Bauer C; Charrat E; Moschke K; Seiki M; Vignes M; Lichtenthaler SF; Checler F; Khrestchatisky M; Rivera S
    Cell Mol Life Sci; 2016 Jan; 73(1):217-36. PubMed ID: 26202697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
    Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease.
    Casali BT; Reed-Geaghan EG; Landreth GE
    J Neuroinflammation; 2018 Feb; 15(1):43. PubMed ID: 29448961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease.
    Beauquis J; Vinuesa A; Pomilio C; Pavía P; Galván V; Saravia F
    Hippocampus; 2014 Mar; 24(3):257-69. PubMed ID: 24132937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.
    Billings LM; Oddo S; Green KN; McGaugh JL; LaFerla FM
    Neuron; 2005 Mar; 45(5):675-88. PubMed ID: 15748844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.